Portugal, SpainPortugal

Malaria Prevention


Madrid/Oeiras - A research team of Spanish, Portugese, Italian, and US-researchers have identified two novel anti-malaria target candidates, that are essential for Plasmodium sporo-zoites invasion to human hepatocytes - the first step in malaria infection. In early November the research team led by Prof. Maria Mota from Madrid University reported that hepatocyte growth factor (HGF) is secreted and activates its receptor MET when sporozoites migrate through hepato-cytes. This activates a signal pathway which induces re-arrangements of the host-cell actin cytoskeleton that is essential for the early development of the parasites within hepatocytes.

Italy, PortugalPortugal


Milan/Sintra – The Italian pharmaceutical company Recordati S.p.A agreed in July to acquire Jaba Farmacêutica (Sintra, Portugal) and all other pharmaceutical businesses belonging to the Grupo Jaba in Portugal. The purchase price...

Italy, PortugalPortugal


Porto Alvo/Catania – Biotech company Alfama recently signed a scientific collaboration agreement with the Department of Biomedical Sciences of the University of Catania (Italy). The purpose of the collaboration is to obtain...



Faro - The University of the Algarve (UALG) has inaugurated a new laboratory for genetic engineering (Bio tério) at its Centre of Molecular and Structural Biomedicine (CMBE) in southern Portugal. The Biotério has as its objective...



Porto - Researchers at the Portuguese Biomedical Science Institute of Porto University say they have discovered a vaccine that could prevent one of the most common health complaints worldwide: dental decay or caries. The vaccine,...



Porto - While a number of European countries debate on how to achieve EU competitiveness goals such as the Barcelona 3% target, other nations have already accepted that such aims will remain out of their reach until 2010.Portugal...



Despite a considerable growth of the private economic sector, a good R&D infrastructure and a generally positive attitude towards biotechnology, a significant biotech industry did not develop in Portugal like it did in other...



Lisbon - Hovione, an international pharmaceutical company and CyDex, Inc., which is creating new pharmaceutical products through innovative drug delivery technologies, recently announced an alliance to develop and commercialize...



Faro - Recent advances in the field of genomics have opened up many exciting avenues of research. Marine biology, however, has largely been excluded from the so called “genomics revolution”. Until now: On May 11, during the...



Tavira - The 3rd Recombinant Protein Production Meeting will take place on November 11-14 this year in the city of Tavira (Algarve) in southern Portugal. The main aim of the meeting is to evaluate and compare the technological...



Oeiras - The start-up Gene Express Lda. is Portugal's first Affymetrix Service Provider. Founded earlier this year by scientists of the Instituto Gulbenkian de Ciência and the Instituto Superior Técnico, the company looks back on...

Displaying results 21 to 30 out of 37

< Previous 21-30 Next >

© 2007-2015 BIOCOM



LentiKat’s offers an unusual investment opportunity

LentiKat’s owns, manufactures and distributes a patented immobilization into lentil-shaped Lentikats Biocatalysts. The unique lentil-like shape of the Lentikats Biocatalyst ensures unlimited diffusion of substrate(s) into any part of the matrix, while still retaining a convenient size for easy separation from the reaction medium. They find application in the Pharma & Food industry (including bio-based chemicals), Wastewater treatment as well as Biofuels. more...

Product of the week


Job Advert

Sales Manager

celares GmbH is a Berlin based drug delivery company focused on chemical modifications of biological drugs. We offer customized development services for international pharma and biopharma companies and have manufacturing capabilities for key starting materials used for the preparation of pharmaceutical drugs. For the intensification of our own sales activities we are looking for a sales manager. more...


All Events



BioVaria 2015

Stock list

All quotes


  • THERAMETRICS0.08 CHF14.29%
  • MEDIGENE10.96 EUR4.88%
  • EVOLVA1.58 CHF3.27%


  • BIOTEST71.00 EUR-3.92%
  • SYNGENTA314.40 CHF-3.65%
  • 4SC5.03 EUR-3.27%


  • 4SC5.03 EUR293.0%
  • WILEX4.33 EUR51.4%
  • SARTORIUS151.00 EUR21.2%


  • CYTOS1.01 CHF-29.4%
  • BIOTEST71.00 EUR-26.9%
  • BIOFRONTERA2.30 EUR-11.2%


  • SANTHERA96.45 CHF2329.5%
  • CYTOS1.01 CHF676.9%
  • WILEX4.33 EUR397.7%


  • MOLOGEN4.94 EUR-55.4%
  • BIOFRONTERA2.30 EUR-29.2%
  • BIOTEST71.00 EUR-20.0%

No liability assumed, Date: 02.05.2015

Current issue

All issues